Prof. Dr. Andreas Mackensen

Lehrstuhl für Innere Medizin V

Arming immune cells for battle: A brief journey through the advancements of t and nk cell immunotherapy (2021) Wendel P, Reindl LM, Bexte T, Künnemeyer L, Särchen V, Albinger N, Mackensen A, et al. Journal article, Review article The IKZF1–IRF4/IRF5 axis controls polarization of myeloma-associated macrophages (2021) Mougiakakos D, Bach C, Böttcher M, Beier F, Röhner L, Stoll A, Rehli M, et al. Journal article A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS (2021) Maccari ME, Fuchs S, Kury P, Andrieux G, Bengsch B, Lorenz MR, Heeg M, et al. Journal article Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma (2021) Rassner M, Waesch R, Schiffer M, Schneider J, Mackensen A, Engelhardt M, Baur R Journal article Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity (2021) Kremer AE, Kremer A, Willam C, Völkl S, Verhagen J, Achenbach S, van der Meijden E, et al. Journal article Human CD4+ T cells specific for dominant epitopes of SARS-CoV-2 Spike and Nucleocapsid proteins with therapeutic potential (2021) Verhagen J, van der Meijden E, Lang V, Kremer A, Völkl S, Mackensen A, Aigner M, Kremer A Journal article CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity (2021) Stoll A, Bruns H, Fuchs M, Nimmerjahn F, Kunz M, Peipp M, Mackensen A, et al. Journal article Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021) Böttcher M, Bruns H, Völkl S, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, et al. Journal article Triton X-114 and Amine-Based Wash Strategy Reduces Lipopolysaccharides to FDA Limit and Achieves Purer, More Potent Recombinant Immunotoxin (2021) George R, Gsottberger F, Ammon AM, Wendland K, Mellenthin L, Mackensen A, Müller F Journal article Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial (2021) Röllig C, Serve H, Noppeney R, Hanoun M, Krug U, Baldus CD, Brandts CH, et al. Journal article